Clinical Trial Update: Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

This update discusses a Phase 2 trial evaluating the efficacy and safety of withdrawing tyrosine kinase inhibitors after a two-step dose reduction in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Tyrosine kinase inhibitors (TKIs) (tyrosine kinase inhibitors)

Snippet

Sponsor: Masaryk University | Conditions: Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug | Phase 2 | Status: ACTIVE_NOT_RECRUITING